JAMES G KAHRS
Allopathic & Osteopathic Physicians|Family Medicine PARK CITY, KS NPI 1821067653
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine KS Lilly USA, LLC All categories
General Payments — all program years on this page
$4,630.66
- Category: General Payments
- Program years: PY2018–2024
- Record count: 375
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,041.59 across 78 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,041.59 | 78 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $211.24 | 19 |
| Acerta Pharma LLC | $150.26 | 5 |
| Novo Nordisk AS | $138.19 | 13 |
| PFIZER INC. | $135.99 | 17 |
| Amgen Inc. | $53.66 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $49.01 | 3 |
| Exact Sciences Corporation | $43.53 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $38.26 | 2 |
| Gilead Sciences, Inc. | $36.36 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $29.87 | 2 |
| Nevro Corp. | $29.65 | 1 |
| GlaxoSmithKline, LLC. | $27.40 | 2 |
| Medtronic, Inc. | $19.50 | 1 |
| ABBVIE INC. | $17.56 | 1 |
| Lundbeck LLC | $17.18 | 1 |
| Hologic Sales and Service, LLC | $16.80 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.97 | 1 |
| Sumitomo Pharma America, Inc. | $13.16 | 1 |
By program year
Records — PY2024 (78)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.